To the Editor: In his recent editorial, Talley discusses a range of risks of proton-pump inhibitors (PPIs).1
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Queensland Diabetes Centre, Mater Hospital, Brisbane, QLD.
Correspondence: adam.morton@mater.org.au
- 1. Talley NJ. Risks of proton-pump inhibitors: what every doctor should know [editorial]. Med J Aust 2009; 190: 109-110. <MJA full text>
- 2. Shiba S, Sugiura K, Ebata A, et al. Hyponatremia with consciousness disturbance caused by omeprazole administration. A case report and literature review. Dig Dis Sci 1996; 41: 1615-1617.
- 3. Bebarta VS, King JA, McDonough M. Proton pump inhibitor-induced rhabdomyolysis and hyponatremic delirium. Am J Emerg Med 2008; 519: e1-e2.
- 4. Mennecier D, Ceppa F, Gidenne S, Vergeau B. Hyponatremia with conscious disturbance associated with esomeprazole. Ann Pharmacother 2005; 39: 774-775.
Online responses are no longer available. Please refer to our instructions for authors page for more information.